Mehboob 2019.
Methods | 3‐arm, unclear blinding, single‐centre, parallel‐group, unclear if RCT, with unclear duration of treatment and unclear duration of follow‐up |
Participants |
Location: Pakistan, 1 site Setting of recruitment and treatment: ENT department of tertiary health care hospital of Karachi, May to September 2018 Sample size: 120 participants (120 ears)
Participant (baseline) characteristics:
Inclusion criteria:
Exclusion criteria:
|
Interventions |
Intervention (n = 40 participants): ciprofloxacin, method of administration not reported, dosage not reported, duration of treatment not reported Intervention (n = 40 participants): co‐amoxicillin, method of administration not reported, dosage not reported, duration of treatment not reported Comparator group(n = 40 participants): untreated Concurrent treatment: not reported |
Outcomes |
Outcomes of interest in the review: Primary outcomes:
Secondary outcomes
|
Notes |
Funding sources: "University Research funding committee of JSMU" Unit of randomisation: person Methods for reporting outcomes of patients with bilateral disease: not reported, only included unilateral presentation of CSOM Hearing thresholds divided into 7 categories as normal (25 dB), mild (26 dB to 34 dB) hearing loss (HL), moderate (50 dB to 64 dB) HL, severe (65 dB to 79 dB) HL, profound (80 dB to 94 dB) HL and deaf Objective: to study the correlation of hearing loss with depression, anxiety and stress in patients suffering from chronic suppurative otitis media in local population of Pakistan Depression, anxiety and stress were scored taking depression, anxiety and stress scale (DASS) as tool and Likert scale was taken for scoring Awaiting author reply regarding randomisation |